Thc most widely used methods for the assay of total bilirubin in serum are based on a coupling reaction with various diazo dyes in the presence of an accelerating agent. The 'direct' reaction, without accelerator, gives a good estimate of the conjugated and protein bound ( 5 ) species of bilirubin only if carefully standardized reaction conditions are used. Enzymatic methods based on bilirubin oxidase appear to give similar results, for both total and direct bilirubin. and through difficult to calibrate, spectrophotometric methods can also give reliable results for total bilirubin at the higher concentrations seen in neonates. More sophisticated HPLC or dry-slide techniques are required for the specific assay of the various conjugated and protein-bound species of bilirubin in serum.
Bilirubin is largely derived from hacmoglobin in senesccnt erythrocytcs, although other hacmcontaining proteins make a significant contribution. In the cells of the reticuloendothelial system the tetrapyrrole ring structure of the haem moiety is enzymatically cleaved by haem oxygenase at the a-methylene bridge and iron is removed to form biliverdin, which is reduced in a reaction catalysed by an N A D dependent enzyme, biliverdin reductase ( Fig. I) .' Bilirubin rcleased into thc blood stream by the cells of the reticuloendothelial system is tightly. but rcversibly, bound to albumin; it can be displaced by a number of drugs and other compounds.' However, irreversible binding can also occur and it is now known that in some jaundiced patients bilirubin is present in the serum covalently bound to albumin. This species has been called 'biloprotein' or &bilirubin.' It is unclear exactly how much unconjugated bilirubin remains unbound or 'free' in the serum since the available methods give quite different results.' Serum bilirubin is taken up by the liver through a mechanism which involves ligandin and is subsequently conjugated. largely with glucuronic acid in a reaction catalysed by UDPglucuronyl transferase.' In normal adults the majority (about 70%) of bilirubin secreted into This review was commissioned by the Analylical Methods Working Party of the Scientific Committee of the ACE. but does not necessarily reflect their views.
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the bilc is diconjugatcd and the remainder is largely monoconjugated. ' In adults serum bilirubin assays are largely used as a test of liver function, which may be compromised by inflammatory or obstructive lesions. The latter are more likely to give rise to increases in the conjugated and protein-bound species in serumh-' but in practice the differential diagnosis of hepatic disease on this basis is rarely clear cut, and only the measurement of total bilirubin is widely used at the present time.
In the neonate red cell life is shorter than in the adult, and this leads to a greater bilirubin burden for hepatic metabolism, which may already be compromised by immaturity of the glucuronyl transferase system. Jaundice is therefore common in the neonate, and in some may be sufficiently severe to require treatment by phototherapy, which requircs frequent monitoring by serum bilirubin assays. A very wide range of neonatal disorders may exacerbate the hepatic compromise by increasing bilirubin formation, and in some severely ill infants, especially if premature, exchange transfusions may be required. Inborn errors of bilirubin metabolism and congenital disorders of the bile duct (biliary atresia) may also present in childhood, and consequently measurements of both unconjugated bilirubin and the conjugated species are required. ' A It has long been held. but never unequivocally proven, that it is the 'free' bilirubin in serum which is toxic, and that kernicterus is consequently prevented by albumin-binding and potentiated by drugs which displace bilirubin from its binding site.' Howcvcr. there arc clinical and experimental inconsistencics with this argument."' and albumin-bound bilirubin may itself have a role in cerebral icterus when thc patency of the blood-brain barrier is diminished.' I' Consequently, free bilirubin assays d o not yet have an established place in clinical chemistry laboratories.
METHODS FOR THE MEASUREMENT OF TOTAL BILIRUBIN
Bilirubin is yellow in colour by virtue of its absorbance at about 450 nm, and its concentration can be measured in serum by spectrophotometric methods. It is also very photolabile. and specimens for bilirubin analysis must be protected from the light prior to a~s a y . "~'~ The spectrophotometric methods require little manipulation of the specimen and have been developed into simple analysers called 'bilirubinometers' which have been widely used in both clinical chemistry laboratories and in baby units for thc rapid asscssment of nconatal jaundice. A chcmical coupling reaction between diazotized sulphanilic acid and bilirubin was first described by Ehrlich, then applied for use in serum by van den Bergh in 1913. Malloy and Evelyn (1937)" and Jrndrassik and Grof (1938)'' published major modifications of the method, which is still the most widely used in clinical chemistry laboratories, However, bilirubin reacts with other diazo-compounds and a number have now also been used for the measurement of serum bilirubin." I' A few other methods for the determination of blood or serum bilirubin have been described. but none is yet widely used in clinical chemistry laboratories.
Spectrophotometric methods
These methods differ in whether the absorbance is measured with or without pre-dilution of the scrum in a suitablc bufer. and in the number and wavelengths of the absorbance measuremcnts.?" The term 'direct' (spectrophotometric) is somctimes used for all these assays. and sometimes only for those madc without dilution bilirubin has a much higher absorbance than unconjugated bilirubin, and its presence in serum will lead to considerable inaccuracies in these assays. 22 The measured absorbance is therefore dependent on the nature and concentration of the species present, on the amount and source of any proteins present, and on the strength and p H of the buffer or diluent. It has been reported that the matrix-dependence with regard to protein can be greatly reduced by the use of a diluent containing caffeine,2n and this may lead to some improvement in the matrix-dependency and haemoglobin interference in these methods2' though not in the accuracy in the presence of &bilirubin.'" Caffeine, with a surfactant, is also used in the spreading laycr of a dry-film spectrophotometric method for bilirubin."." In this method, serum bilirubin is exposed to a binding agent at pH 8.0 and the light reflected from the slide is measured at two wavelengths to allow for the different maxima of the unconjugated (420-425 nm) and conjugated species (460465 nm). This is the only spectrophotometric method which allows determination of the conjugated and unconjugated species as well as total bilirubin (although it does not measure protein-bound &bilirubin, which does not penetrate from the spreading layer).
Interference in these methods arises from any other serum components which absorb light at the chosen wavelengths. In practice, problems arise with regard to haemoglobin, carotenoids, and turbidity, but in most methods, the measureing wavelengths are chosen to minimize haemoglobin interference, the main problem in the neonate. However, the extent to which this can be achieved is very variable, and haemoglobin may cause either over or under estimation of the bilirubin concentration.2b
Recently, an optical device for the transcutaneous measurement of bilirubin has been designcd, and is now available commercially. This instrument measures the light at 450 nm reflected from the bilirubin-stained skin in arbitrary units which can correlate quite well with serum concentrations." However, the instrument cannot be standardized by conventional means and must be directly correlated with the serum method in use for a given nursery population so that suitable action limits can be identifi~d.'~ It is also somewhat operator depen-dent34 and cannot be used in patients undergoing phototherapy or t r a n s f u~i o n~' .~~ which greatly reduces its usefulness in a busy clinical unit. However, the instrument is non-invasive, and of the serum; 'direct' means something quite differcnt with regard to thc diazo mcthods and is probably best avoided in the spcctrophotometric context. In most methods two absorbances are measured. one near the bilirubin peak and one at a higher wavelength as a blank against a number of possible interfering compounds. Since the different bilirubin species have diKerent absorbance spectra?" 2 and the interfering compounds have a range of overlapping absorbances.'" both peak and blank wavelengths are compromises, generally arrived at empirically. Nonetheless, methods using more than two wavelengths seem to offer little practical advantage.'"
A detailed survey and cxamination of thesc methods was made somc time ago.'" Numerous Combinations of buffers and wavelengths were compared, and it was concluded that a dilution in tetraborate buffer (100 mmol/L) was required to provide a medium of well-defined pH (9.3) and ionic strength for the absorbance measurements, which were then best made at 466nm (the isosbcstic point between unconjugated and conjugated bilirubin) and 522 nm (as blank). This method is commonly known by the name of the first author of this study. Hertz, and is now widcly used for neonatal serum bilirubin determina ti on^.''.^^ For measurements made on scrum without dilution, wavclcngth combinations of 461 / 551 nm or 455 114575 nm are popular's but many other combinations have been used.'" In some methods the wavelength difference may be compared with spectrophotometric (e.g. filter) standards or with sera of known bilirubin concentration. and in others the measured absorbances may be inserted into a formula for conversion to a bilirubin concentration based upon an estimated molar absorbance of bilir~bin.'".'~.'~ Any spectrophotometer fitted with suitable optical cells can be used for these assays, but dedicated instruments ('bilirubinometers') are available and are intended to simplify the measurements for use in neonatal units or ward side-rooms. Of three such instruments used and evaluated in the UK,2h one requires the serum to be diluted in pH-adjusted saline before the absorbance measurements are made at 454/540 nm, while the others use undiluted serum and wavelength combinations of 460/550 nm and 455/ 575 nm, respectively.
The diversity of spectrophotometric methods is at least partly due to the known spectral dissimiliarity of the different bilirubin species present in serum and their matrix dependence.'" "."
In particular, S-undoubtedly better than visual assessment of jaundice;'" it may have a place in screening jaundiced but otherwise healthy infants and may reduce the need for serum assays."
Diazo-dye methods
In the diazo coupling reaction bilirubin is attacked at the central methcne group to form two dipyrroles and subsequently two azobilir~bins.'~ Bilirubin may be Conjugated at the C8 or C12 position ( Fig. I ), or both, and the azobilirubin formed may therefore also be conjugated. according to the nature of the parent molecule. In most sera probably both conjugated and unconjugated azobilirubin are present initially. but the conjugated pigment rapidly hydrolyses at room temperature in alkali." Although the C8 and C12 azopigments have a different polarity, and can be separated chromatographically, they have the same absorption spectra." This is vcry pH dependent. and the pigment is red at acid pH. with an absorbance peak near 500nm. and blue in alkali. with an absorbance peak near 600 nm. The latter is more appropriate with regard to interfering substances, but the pigment is less stable in alkali in the absence of stabilizing agents .411
The reaction seems to take place in at least two phases. the first of which requires an excess of diazo reagent and the second an excess of sulphanilic acid to achieve maximum velocity and reach ~o m p l e t i o n .~' This is in part due to competing reactions with other serum or chemical components of the reaction mixture. In these conditions and at acid pH the reaction with conjugated bilirubin is very rapid and complete but &bilirubin reacts more slowly." However, the reaction with unconjugated bilirubin is very pH dependent, and the rate falls off rapidly in acid conditions.'" To reduce this pH dependence with unconjugated bilirubin a number of compounds can be used to increase the rate of diazotization or 'accelerate' the reaction even at pH below 6. It has been widely assumed that the poor diazo reactivity of unconjugatcd bilirubin is due to its poor solubility in aqueous solutions at acid pH, and that these agents somehow increase this solubility, but the mechanism for their action is not at all clear. The compounds used for this purpose include methanol, caffeine, sodium benzoate, dyphylline, and sodium dodecyl sulphate or other surfactant, either singly or in combinat i~n .~~"~ Earlier methods using methanol as an accelerating reagent tended to cause protein within 2 min.??.'8.jl denaturation, which was therefore minimized by high serum dilutions.'s Such methods lack sensitivity and are very matrix-de~endent.~' Consequently they no longer have a place in clinical chemistry laboratories. since accelerating agents compatible with serum proteins such as caffeine, dyphylline, and surfactants have repeatedly been shown to be more satisfac-
The diazo methods for bilirubin assay have been automated in continuous flow analysers for some time."" but they generally involve several reagent additons and consequently were far less easily adapted to the early centrifugal or other discrete analysers in which more than one reagent addition was slow or difficult. In addition. diazotized sulphanilic acid is not a very stable reagent. and there arose considerable interest in the use of other morc stable diazo salts which could be coupled with bilirubin in onc-step methods Tor centrifugal a n a l y~e r s .~~ Several different diazo reagents have now been used, including derivatives of dichloroaniline and dich-l~r o p h e n o l . '~ '') For similar reasons, the Kodak dry-film reagent contains a very stablc diazonium salt, 4-N-carboxymethylsulphamyl-benzenediazonium hexafluorophosphate, together with dyphylline and a surfactant in the spreading layer," while the Amcs Seralyser method uses papcr impregnated with diazotized dichloroaniline and dyphylline. 47 Blanks are necessary to reduce interference from a number of serum constituents. and on some automated analysers blanks are not easy to set up, may slow down throughput and of course double the sample volumc required (which may not be acceptable for paediatric use). Several diazo methods with bichrornatic blanking have therefore been described, but the selection of the peak and blank wavelengths is critical and dependent not only on the diazo salt but also on the exact reaction conditions, especially pH, and the behaviour of any interfering com-Interference in diazo mcthods may arise from turbidity, haemoglobin, indican, metal ions, and the drugs L-dopa and a-methyldopa. The latter is not a common problem, and the effects, if any, of most metal ions are small and unlikely to be a problem if good quality reagents are used, especially in the presence of the chelating agent EDTA which is included in many method^.^"'^ Zinc significantly enhances the absorbance of the azopigment whether added prior to or following the coupling reaction. However, the effect of en-
The unulysis of bilirubin in serum I23 interfering agents. For this reason a 'standard mcthod' has becn proposedJH bascd upon that of Jcndrassik and Grof.'b In this method bilirubin is rcactcd with diazotized sulphanilic acid at acid pH in the presence of caffeine and sodium benzoate, and then alkaline tartrate is added (with ascorbic acid for haemolysed sera to stabilize the azopigment) to raise the pH for the absorbance measurement, which is made at 600nm. The method can be automated using both continuous flow and discrete analysers, and has recently been shown to measure pure unconjugated and conjugated bilirubin quantitati~ely.~'
Enzymatic methods
An enzymatic method for the measurement of bilirubin in serum has recently been described.5' It depends upon a bilirubin oxidase isolated from the microorganism iWyrottirc.iurn verrucariu which catalyses the oxygen-dependent convcrsion of bilirubin to biliverdin (the reverse of the biliverdin reductase rcaction, Fig. I ). The enzyme has optimal activity at pH 8 towards both conjugated and unconjugated bilirubin, and although these two species have different absorbance peaks at this pH, the decrease in absorbance at 425nm gives good agreement with thc diazo methods for most scra. Protein-binding reduces the rcaction rate, and it is necessary to includc an anionic detergent to rclcasc albumin-bound unconjugated bilirubi n. 5q.M) Originally it was reported that, like the spectrophotometric and diazo methods, the enzymatic method gave low results in the prescnce of haemoglobinSH though the mechanism for this effect was not known. However, the effect of haemoglobin was negligible in a recently dcscribed method which included EDTA in the reagent. b'
Other methods
A few other methods for the measurement of total bilirubin in serum have been described. including a method based upon the fluorescence of bilirubin bound to protein or detergent6' and an electrochemical technique.63 Neither method is widely used in clinical chemistry laboratories. dogenous or contaminating zinc is considered too small to justify supplcmentation of the diazo reagent."' Turbidity (usually lipacmia) can be a problem in all colorimetric mcthods, but both caffeine and surfactants have clearing properties and reduce its Its effcct can be further reduced by careful use of conventional or bichromatic blanks. or by clearing the serum with lipase.5'
Indican may bc prcsent in the serum from uraemic patients, and reacts with various diazo reagents to give azopigments with absorbance in the vicinity of that of azobilirubin. The worst affected methods are those using dichlorophenyl diazonium salts," but even in thcsc methods shortening the rcaction time may make this intcrfcrcncc ncgligiblc." Diazotizcd sulphanilic acid mcthods arc much lcss susccptiblc to intcrfcrcncc from indican.53
As in the spectrophotometric methods, hacmoglobin may causc spectral intcrfcrencc in the diazo methods."' but it also intcrfercs with the diazo rcaction by more complex and lcss well undcrstood mechanisms. These may include destruction of bilirubin prior to its direct interference with the diazo coupling reaction.'I and destruction of the formed azopigment.55 I t may be that more than one mechanism is involved. and the predominating mechanism in a particular method will depend not only on the haemoglobin concentration but also on the bilirubin concentration. wavelcngth(s) used. incubation time. reaction and mcasurement pH. diazonium salt uscd. and even on the age of the sample.'" I t is known that ascorbic acid and some other can reduce thc instability of the alkaline azopigment in thc prcsencc of haemoglobin in somc mcthods. However. ascorbic acid also destroys the diazo reagent and stops the coupling reaction. so it is added to the azopigment when thc reaction has been completed." Similarly, some haem-binding agents may reducc hacmoglobin interference. and the two xanthine derivatives used as accelerating agents (caffeine and dyphylline) are particularly useful in this rc~pcct.~' Somc authors prcfcr dyphyllinc sincc it is more soluble than caffeinc and can be uscd in highcr c~ncentration.~" Haem-binding is one reason why these reagents are included even when other accelerators such as surfactants are Thus, the diazo reaction has many variables and is inconsistently affected by a number of used ,43.48.4q
METHODS FOR THE MEASUREMENT OF BILIRUBIN SPECIES

Liquid chromatography
In recent years the nature of the bilirubin species present in normal and pathological serum has been clarified by the application of HPLC techniques. These may involve the preparation and chromatography of bilirubin dcrivatives. or the extraction and chromatography of the native species.
The first such technique applied to serum involved normal-phase HPLC of bilirubin and its methyl esters derived from the glucuronides by treatment with a methanolic solution of potassium hydroxide (alkaline methanolysis).u Proteins are precipitated in this procedure, and bilirubin and its esters are extracted into chloroform for HPLC, which separates bilirubin and its dimethyl ester and even both C8 and CI 2 monomethyl esters formed from the equivalent monoglucuronides. Pretreatment of the sample with caffeine/benzoate improves the recovery of the conjugated bilirubin species." and its sensitivity can be further increased by use of .a reversed phase HPLC technique, largely because carotcnoid interference is avoided and the C8 and C12 monomethyl esters run together." In this way thc method has been used to demonstrate the presence of predominantly unconjugated bilirubin but also small amounts of both the mono-and di-glucuronide conjugates even in normal serum.M The biggest disadvantage of this technique is the protein precipitation, since the precipitate can carry significant amounts of bilir~bin.'~ In an alternative technique serum globulins, but not albumin, are precipitated by means of sodium sulphate, after which reversed-phase HPLC of the ascorbate stabilized bilirubin species reveals four peaks from icteric sera due to not only unconjugated (I), monoconjugated (8) and diconjugated (7) bilirubins, but also a bilirubin species (6) which co-elutes with albumin.h7 Only a small proportion of the total bilirubin is precipitated with the globulin. and in pathological sera as much as 80% of the total bilirubin may be found in the albumin-bound &bilirubin peak.'.b7 More recently, a reversedphase Micronex HPLC method has been described which avoids protein precipitation altogether, and this technique can detect both free and protein-bound species and also bilirubin photoderivatives.b8
The protein-bound species &bilirubin can also be determined by a more simple anion-exchange chromatographic technique combined with the d i a z o -r e a~t i o n .~~ The diazo-products of 6bilirubin are protein bound and free in solution in equal amounts, and the former can be determined because it remains in solution after treatment with the ion-exchange resin.
Spectrophotometric methods
Thc conjugated and unconjugated bilirubin species in serum can also be estimated by a dryfilm spectrophotometric te~hnique.~" This dual wavelength technique uses the spectral differences between mordant-bound unconjugated (peak at 460nm) and conjugated bilirubin (peak at 420 nm) to measure their concentration in mixtures of the two. Since thc method does not measure the protein-bound &bilirubin which is retained in the spreading layer, an estimate of the &bilirubin concentration can be obtained by subtracting the sum of the unconjugated and conjugated species from the total bilirubin measured by the diazo dry-film method which measures all the species in serum. Values for the bilirubin species in serum measured in this way correlate well with the more sophisticated HPLC separation^.'^^^'
Direct bilirubin assays
It has bcen known for many years that the serum from some jaundiced patients reacts rapidly with diazo reagents even in the absence of an accelerator. The reasons for this were less than clear and the subject of much speculation, but many authors assumed that it was due to the greater solubility of the conjugated species, and there was a consequent tendency to use the terms 'direct' bilirubin and 'conjugated' bilirubin synonymously. It is now known that both the conjugated species and protein-bound Sbilirubin are direct-reacting in diazo methods, and it is no longer appropriate to assume that direct bilirubin is entirely or even largely conjugated glucuronides. ',22 Methods which attempt to differentiate between the direct and indirect reacting species must use diazotized sulphanilate at acid pH, because unconjugated bilirubin has a significant activity at pH values above 6.4' In addition, a small proportion of unconjugated bilirubin will react even at low pH in most methods, particularly those which use high concentrations of sodium nitrite.7' On the other hand, the soluble species (i.e. the glucuronides and &bilirubin) may themselves not react quantitatively in the direct reaction, especially when compared with their reaction in the presence of accelerators7 or when short reaction times are used.22 Further, these species behave differently in the direct reaction according to the concentration of diazo reagent and acid buffer used. 22 Pathological serum may contain varied con-
The unalysis qf bilirubin in serum 125 fluorescence of albumin-bound bilirubin'" or the quenching of albumin fluorescence by such binding7' have been applied to the measurement of the bilirubin binding capacity and saturation of serum samples. When used in this way the methods may correlate quite well, but it is not clear how far they are really measuring the same thing,62.74.8u
centrations of the direct-reacting species, and their apparent concentration in these methods will clearly be dependent upon the exact reaction conditions used. It is therefore not surprising that direct bilirubin assays in use in different laboratories give quite different results." Some methods are frankly i n a~c u r a t e~' . '~ and even the best are probably insufficiently accurate to allow differentiation betwcen the unconjugated and soluble species at total bilirubin concentrations below about 5Opmol/L.
It is important to note that despite these limitations it is possible to measure direct bilirubin in conditions which give a good correlation with more sophisticated assays of conjugated and protein-bound bilir~bin.'~ However, it is vital that the reaction conditions used are selected carefully and reproduced consistently, since relatively small changes in the concentrations of the components or procedure can lead to misleading resU~ts.?2.41. 71.72 Since it is known that thc Jendrasik and Grof direct reaction gives a good correlation with the soluble species, it would seem to bc the method of choice in this re~pect.'~
Enzymatic methods
It has recently been reported that the enzymatic bilirubin oxidase method for serum bilirubin can be modified to measure the 'direct' species by lowering the reaction pH from neutral to acid so that the unconjugated species is not oxi-These methods measure both conjugated bilirubin and &bilirubin together at low pH, but only the former is oxidized at alkaline pH and it can be measured selectively in this way." Comparisons with the diazo and dry-dized,5q b1. 73 and HPLC methods"' are good. slideh[~.hl.7'
Free bilirubin assays
Attempts have been made to measure 'free' bilirubin in a number of ways, but it is not clear how far the different bilirubin species will react or interferc in each method. Perhaps as a result, they give quite different results and may also lack p r e c i s i~n~.~' ,~' and only two are suitable for use in clinical laboratories. The peroxidase technique is based on the principle that free bilirubin is rapidly oxidized by horseradish peroxidasc, while the albumin-bound species is protected from this rea~tion.~' The Sephadex elution technique depends upon the retention of unbound but not bound bilirubin by a Sephadex column. 77 These methods, and others based upon the
STANDARDIZATION OF SERUM BILIRUBIN ASSAYS
The preparation of suitable materials for the standardization of bilirubin assays is compounded by the variability and instability of bilirubin preparations, the nature and variable concentration of the different species present in serum and their different behaviour in virtually all methods. This subject has recently been reviewed.n' Only unconjugated bilirubin is readily available in pure (crystalline) form; it is poorly soluble in water and unstable, especially to light and oxidation. It is more soluble but no more stable in DMSO, chloroform, alkali, and aqueous protein solutions, but its spectral behaviour is very dependent on the nature of the solvent and any impurities present.13 Similarly, while bilirubin is more soluble in aqueous solutions in the presence of proteins, its absorbance peak and absorptivity are dependent on both the source and nature of the proteins.27 Even different preparations of the same protein may yield different results,M2 and for the spectrophotometric mcthods human serum or protein based standards are e~sential;'~ indeed, no synthetic standard can be considered entirely satisfactory for these methods. and some regard the use of pools of neonatal serum as the only alternative.M3 Standards prepared in human serum were also essential for older diazo methods using methanol as an accelerator,'' but those based upon the method of Jendrdssik and Grof are more robust in this respect and standards in either human or bovine albumin can be used sati~factorily'"~~ though the human material is refera able.^^ A number of methods have been described for dissolving the currently available purified bilirubin preparations in serum or protein solutions. These generally involve taking an accurately weighed quantity of crystalline bilirubin into a suitable solvent, such as DMSO or sodium hydroxide or sodium carbonate solutions, before diluting it into the serum or protein so~ution~27.42.44.8? However, bilirubin is unstable in strong alkali, DMSO solutions are less easily added to the protein diluent, and some preparations are very difficult to completely dissolve in sodium carbonate. A more successful compromise involves suspending the bilirubin in a small amount of DMSO before dissolving in sodium carbonate solution and mixing with the protein-containing dil~ent.".~? The preparation of primary standards in this way requires care and attention to detail, and for this reason many laboratories use commercially available secondary standards." It is essential that these are calibrated against a properly prepared primary standard for the method in use, either by the laboratory or by the supplier of the material. Some commercially available materials may not be suitable for use with spectrophotometric method^."'.^' For both spectrophotometric and diazo methods, artificial standards based on dyes with similar absorbance to bilirubin or its azo derivatives have been used." These obviously d o not behave in the same way as bilirubin ana are a check on the performance of the spectrophotometer only; nonetheless, they may have a place in improving comparability between l a b o r a t~r i e s .~' ,~~ Some laboratories use instruments calibrated against a bilirubin standard or an assumed molar absorbance of bilirubin or its azo derivative.26 All these methods of standardization are very dependent upon the use of stable and reproducible reaction and spectrophotometric measurement conditions, which are very difficult to achieve in practice.
There are currently no standards available for diazo-direct bilirubin assays, and this together with the variety of reaction conditions in use account for the apparently very poor performance of the methods in EQAS surveys.23 At present there seems no alternative to the use of ditaurobilirubin or unconjugated bilirubin as standards:2 the former is at least direct-reactive, but neither species is actually a true direct-reacting component of serum.
QUALITY CONTROL OF SERUM BILIRUBIN ASSAYS
The preparation of suitable materials for use in internal quality control suffers from exactly the same problems as those mentioned for standards. However, the precise bilirubin concentration is obviously less critical, and the main requirement is behaviour corresponding to that of the charac-teristic specimen. Consequently. human serum based materials are desirable for effective internal quality control of spectrophotometric methods. although animal or human serum based solutions may be adequate for the diazo methods.
Total bilirubin conccntrations up to about 120 pmol/L are rcgularly surveyed in a numbcr of external quality asscssrncnt schemes in thc U K and elsewherc, but there have been only a few surveys at the higher concentrations measurcd in paediatric laboratories and nconatal One reason for this is the lack of uni ts.2'.?4,n5.nx suitable materials for distribution, since both spectrophotometric and diazo methods are in use and non-human based materials may give considerably different results for these two Furthermore. those materials currently available for the quality control of paediatric assays almost invariably have bilirubin concentrations in the range 300-370pmol/L, and there is a deficiency of material with concentrations in the range 100-300 pmol/ L. This range is of great clinical importance now that the treatment of hyperbilirubinaemia is largely required in sick, often pre-term, infants where the action limits are much lower than for healthy term babies."
ANALYTICAL GOALS AND ACHIEVABLE PERFORMANCE TARGETS
Various criteria have been proposed for determining thc allowable analytical variation for assay procedures. Frascr"' has classificd these as based on reference or therapeutic ranges. views of clinicians, the state of the art. biological variation or the views of 'expcrt' groups. The study of biological variability both within and between individuals is probably the most scientifically sound procedure for analytical goal setting. and with respect to bilirubin this would require a coefficient of variation of 11.3%.
External Quality Assurance schemes provide useful indications of the 'state of the art' for analytical performance, and data published in the UK over the last few years and summarized by Fraserw indicate that for bilirubin the pcrformance (expressed as one standard deviation) achieved by 50% of the participating laboratories has improved from 6,5pmol/L in 1971 to 2.34pmol/L in 1986 in the assay range 33-99 prnol/L. This indicates an achievable performance of 3.6% or better (coefficient of variation) in half the participating laboratories. 127 of Clinical Biochemists Analytical Methods Working Party for their helpful criticisms during the preparation of this manuscript.
The analysis of bilirubin in serum
However, it should be emphasked that both quality assurance survcys and biological variability studies may examine differcnt analytical ranges to those which are clinically important, so that the results need to be intcrpretcd with caution. Thus, for the neonate clinicians must be able to identify an abnormally rapid increase in bilirubin concentration sufficiently early to allow appropriate treatment, and it has been suggested that a coefficient of variation in the order of 2% is required for this purpose.n5
CONCLZJSION
At the present time diazo methods appear to be the most suitable for laboratories requiring a rapid and reliable method for total bilirubin assay with optimal performance in the range up to ISOpmol/L. Those based upon the method of Jendrassik and Grof are precise and reliable and correlate well with HPLC methods for determination of both total and direct-reacting bilirubin species present in serum.
When measurements of the direct component are not required, a number of other diazo mcthods may also perform satisfactorily provided care is takcn to minimizc interference from haemoglobin and indican. It remains to be seen whether the newly described dry slide or enzymatic methods will perform as well as the conventional diazo methods in external quality assessment schemes.
Optimal precision in the higher ranges as required in paediatrics can be obtained with either spectrophotometric or diazo methods, which give equivalent results even in infants undergoing p h~t o t h e r a p y . '~ For the clinical chemistry laboratory the Jendrassik and Groffbased diazo methods suffer less from haemoglobin interference, allow determination of the direct component, and are simpler to standardize; neonatal units may obtain better results with simpler spectrophotometric methods" provided that they are carefully standardized and controlled." However, as Turnell"' has pointed out, there is no universal calibrant for the assay of serum bilirubin at the present time.
Transcutaneous bilirubinometry currently offers an improvement on visual assessment of jaundice, but cannot replace serum bilirubin assays. Measurement of 'free' bilirubin remains of unproven clinical value.
